Albert Bourla’s gamble to forgo federal help to develop Pfizer-BioNTech’s coronavirus vaccine paid off when the Food and Drug Administration granted full approval for the shots on Monday.
Pfizer’s CEO recalled his decision to go it alone and how the company is applying what it learned to future drug development, in an exclusive interview today with Crain’s.
“I know that bureaucracy and innovation are like water and oil,” said Bourla, who is also chairman of the Manhanttan-based drug company. “I wanted to protect this team from both internal and external bureaucracy. We knew that if we accepted governmental funds, we would have to answer to them. When I
→ Continue reading at Crain's New York Business